Denali Therapeutics Inc. DNLI Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s preferred stock, shares authorized?
- Denali Therapeutics Inc. (DNLI) reported preferred stock, shares authorized of $40M in Q1 2026.
- How has Denali Therapeutics Inc.'s preferred stock, shares authorized changed year-over-year?
- Denali Therapeutics Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $40M to $40M.
- What is the long-term trend for Denali Therapeutics Inc.'s preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $40M to $40M.